We are live on ! Find out more
OPTR

OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR

Delisted

OPTR was delisted on the 23rd of October, 2013.

Back to rankings

103 hedge funds and large institutions have $642M invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q2 according to their latest regulatory filings, with 103 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more call options, than puts

Call options by funds: $20.5M | Put options by funds: $16.4M

Holders
103
Holders Change
+103
Holders Change %
–
% of All Funds
3.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
103
Increased
–
Reduced
–
Closed
–
Calls
$20.5M
Puts
$16.4M
Net Calls
+$4.08M
Net Calls Change
+$4.08M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MWAM
101
Mariner Wealth Advisors (Madison)
Kansas
$5K +$4.73K +325 New
MWNA
102
Marshall Wace North America
New York
$5K +$5.07K +348 New
JG
103
Jefferies Group
New York
$2K +$1.97K +135 New
1 2 3 4
5

OPTR Hedge Fund Activity: Q2 2013 in Review

103 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q2 2013, worth a combined $642M.

Buyers outnumbered sellers: 103 funds opened new OPTR positions and 0 closed out — a net gain of 103 holders — while 0 added to existing stakes and 0 trimmed.

  • 103 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $642M of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q2 2013.
  • 103 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q2 2013 and 0 closed out, a net change of +103 holders.

Based on aggregated 13F filings for Q2 2013.